vimarsana.com

Latest Breaking News On - Dr reddy amp 039 s - Page 1 : vimarsana.com

Antitrust Litigation Filed Against Dr Reddy s Laboratories In US

Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US.

Trying To Bring Sputnik M Vaccine For 12-18 Age Group To India: Dr Reddy s

Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.

Exclusive: Mumbai Gets 3 Bids From Russia s Sputnik Covid Vaccine Makers

Exclusive: Mumbai Gets 3 Bids From Russia s Sputnik Covid Vaccine Makers Exclusive: Mumbai Gets 3 Bids From Russia s Sputnik Covid Vaccine Makers The RDIF s bids for Mumbai comes when Punjab and Delhi have said that private firms have refused their request for Covid vaccine supply. RDIF has said it will transfer one crore Sputnik V doses to BMC in 60 days. New Delhi: Mumbai has received three bids for the supply of Russia s Sputnik V Covid vaccine, government sources have said. The city s civic body had earlier this month placed global tenders for one crore doses. The Brihanmumbai Municipal Corporation (BMC) had placed the tenders on May 11. These were issued under India s latest nationwide COVID-19 inoculation policy, allowing state governments to procure Covid vaccine doses directly from producers.

Coronavirus - Arvind Kejriwal: Have Asked Dr Reddy s For 67 Lakh Sputnik V COVID-19 Vaccine Doses

Coronavirus: Sputnik V Shot To Cost Rs 750, To Arrive By May June: Dr Reddy s To NDTV

Dr Reddy s will ramp up manufacture of the vaccine in India after the initial imports. New Delhi: Russia s Sputnik V Covid vaccine will be sold at $10 (around Rs 750) a dose in India, its India manufacturer Dr Reddy s Labs has told NDTV. Several hundred thousand doses will be available in the country in May-June through imports, says GV Prasad, Managing Director of Dr Reddy s. Sputnik V is the third vaccine to be cleared for use in India at a time the country s demand is expected to shoot up after vaccinations are opened to all adults from May 1. Asked how many doses would be available by May-June, Mr Prasad said: That is still being negotiated, by several hundred thousand is my view.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.